JP2018513138A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513138A5 JP2018513138A5 JP2017550832A JP2017550832A JP2018513138A5 JP 2018513138 A5 JP2018513138 A5 JP 2018513138A5 JP 2017550832 A JP2017550832 A JP 2017550832A JP 2017550832 A JP2017550832 A JP 2017550832A JP 2018513138 A5 JP2018513138 A5 JP 2018513138A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- weight
- polyethylene glycol
- polyvinyl alcohol
- russia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562141981P | 2015-04-02 | 2015-04-02 | |
| US62/141,981 | 2015-04-02 | ||
| PCT/US2016/025176 WO2016161069A1 (en) | 2015-04-02 | 2016-03-31 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020016858A Division JP2020073583A (ja) | 2015-04-02 | 2020-02-04 | ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513138A JP2018513138A (ja) | 2018-05-24 |
| JP2018513138A5 true JP2018513138A5 (https=) | 2019-03-14 |
| JP6713483B2 JP6713483B2 (ja) | 2020-06-24 |
Family
ID=55806767
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017550832A Active JP6713483B2 (ja) | 2015-04-02 | 2016-03-31 | ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形 |
| JP2020016858A Withdrawn JP2020073583A (ja) | 2015-04-02 | 2020-02-04 | ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020016858A Withdrawn JP2020073583A (ja) | 2015-04-02 | 2020-02-04 | ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形 |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US20160287573A1 (https=) |
| EP (1) | EP3277278B1 (https=) |
| JP (2) | JP6713483B2 (https=) |
| KR (1) | KR20170132325A (https=) |
| CN (1) | CN107820424B (https=) |
| AU (1) | AU2016243691A1 (https=) |
| BR (1) | BR112017021120A2 (https=) |
| CA (1) | CA2980328A1 (https=) |
| CY (1) | CY1122828T1 (https=) |
| DK (1) | DK3277278T3 (https=) |
| ES (1) | ES2774473T3 (https=) |
| HK (1) | HK1247105A1 (https=) |
| HR (1) | HRP20200432T1 (https=) |
| HU (1) | HUE048785T2 (https=) |
| IL (1) | IL254593A0 (https=) |
| LT (1) | LT3277278T (https=) |
| ME (1) | ME03671B (https=) |
| MX (1) | MX2017012474A (https=) |
| PH (1) | PH12017501767A1 (https=) |
| PL (1) | PL3277278T3 (https=) |
| PT (1) | PT3277278T (https=) |
| RS (1) | RS60074B1 (https=) |
| RU (1) | RU2017134794A (https=) |
| SI (1) | SI3277278T1 (https=) |
| SM (1) | SMT202000157T1 (https=) |
| TW (1) | TW201642856A (https=) |
| WO (1) | WO2016161069A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1247105A1 (zh) | 2015-04-02 | 2018-09-21 | Theravance Biopharma R&D Ip, Llc | Mu类鸦片受体拮抗剂与类鸦片药剂的组合剂型 |
| JP7222244B2 (ja) * | 2017-08-08 | 2023-02-15 | 三菱ケミカル株式会社 | 医薬錠剤、およびその製造方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001526228A (ja) | 1997-12-22 | 2001-12-18 | ユーロ−セルティーク，エス．エイ． | オピオイド作動薬／拮抗薬の併用 |
| US6419960B1 (en) | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
| AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
| US7842307B2 (en) | 2001-08-06 | 2010-11-30 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent |
| ATE431738T1 (de) * | 2001-08-06 | 2009-06-15 | Euro Celtique Sa | Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist |
| AU2003301121A1 (en) * | 2002-12-18 | 2004-07-14 | Pain Therapeutics, Inc. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
| CA2540308C (en) | 2003-09-26 | 2013-08-06 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
| TWI415635B (zh) | 2004-05-28 | 2013-11-21 | 必治妥施貴寶公司 | 加衣錠片調製物及製備彼之方法 |
| NZ560828A (en) * | 2005-03-02 | 2011-01-28 | Theravance Inc | Quinolinone compounds as 5-HT4 receptor agonists |
| ES2366058T3 (es) * | 2006-03-01 | 2011-10-14 | Theravance, Inc. | Compuestos de 8-azabiciclo[3.2.1]octano como antagonistas de los receptores opioides mu. |
| MY145633A (en) | 2006-03-01 | 2012-03-15 | Theravance Inc | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| CN101500542A (zh) * | 2006-07-11 | 2009-08-05 | 共有药物有限公司 | 控释制剂 |
| TWI409067B (zh) | 2007-02-28 | 2013-09-21 | Theravance Inc | ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型 |
| TWI415850B (zh) | 2007-07-20 | 2013-11-21 | Theravance Inc | 製備ｍｕ類鴉片受體拮抗劑之中間物的方法 |
| WO2009137672A1 (en) * | 2008-05-07 | 2009-11-12 | Salix Pharmaceuticals, Ltd. | Methods of treating bowel disease by administering a bowel cleanser and an antibiotic |
| EP2210595A1 (en) | 2009-01-14 | 2010-07-28 | LEK Pharmaceuticals d.d. | Active coating of pharmaceutical dosage forms |
| CN102421423B (zh) * | 2009-05-12 | 2014-11-05 | Bpsi控股有限责任公司 | 增强型防潮即释薄膜包衣系统和覆有该包衣的基体 |
| IT1398930B1 (it) * | 2010-03-24 | 2013-03-28 | Molteni & C | Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi. |
| EP2611442B1 (en) * | 2010-09-03 | 2018-07-04 | Bristol-Myers Squibb Company | Drug formulations using water soluble antioxidants |
| BR112013019026A2 (pt) | 2011-02-01 | 2016-10-04 | Astrazeneca Uk Ltd | formulações farmacêuticas incluindo um composto amina |
| US9339489B2 (en) * | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| HK1247105A1 (zh) | 2015-04-02 | 2018-09-21 | Theravance Biopharma R&D Ip, Llc | Mu类鸦片受体拮抗剂与类鸦片药剂的组合剂型 |
-
2016
- 2016-03-31 HK HK18106740.0A patent/HK1247105A1/zh unknown
- 2016-03-31 PT PT167180629T patent/PT3277278T/pt unknown
- 2016-03-31 ES ES16718062T patent/ES2774473T3/es active Active
- 2016-03-31 MX MX2017012474A patent/MX2017012474A/es unknown
- 2016-03-31 RU RU2017134794A patent/RU2017134794A/ru not_active Application Discontinuation
- 2016-03-31 HR HRP20200432TT patent/HRP20200432T1/hr unknown
- 2016-03-31 ME MEP-2020-48A patent/ME03671B/me unknown
- 2016-03-31 HU HUE16718062A patent/HUE048785T2/hu unknown
- 2016-03-31 LT LTEP16718062.9T patent/LT3277278T/lt unknown
- 2016-03-31 CN CN201680019821.7A patent/CN107820424B/zh active Active
- 2016-03-31 SM SM20200157T patent/SMT202000157T1/it unknown
- 2016-03-31 CA CA2980328A patent/CA2980328A1/en not_active Abandoned
- 2016-03-31 KR KR1020177031800A patent/KR20170132325A/ko not_active Withdrawn
- 2016-03-31 JP JP2017550832A patent/JP6713483B2/ja active Active
- 2016-03-31 BR BR112017021120-3A patent/BR112017021120A2/pt not_active Application Discontinuation
- 2016-03-31 WO PCT/US2016/025176 patent/WO2016161069A1/en not_active Ceased
- 2016-03-31 PL PL16718062T patent/PL3277278T3/pl unknown
- 2016-03-31 RS RS20200315A patent/RS60074B1/sr unknown
- 2016-03-31 EP EP16718062.9A patent/EP3277278B1/en active Active
- 2016-03-31 DK DK16718062.9T patent/DK3277278T3/da active
- 2016-03-31 TW TW105110406A patent/TW201642856A/zh unknown
- 2016-03-31 AU AU2016243691A patent/AU2016243691A1/en not_active Abandoned
- 2016-03-31 US US15/086,816 patent/US20160287573A1/en not_active Abandoned
- 2016-03-31 SI SI201630671T patent/SI3277278T1/sl unknown
-
2017
- 2017-09-19 IL IL254593A patent/IL254593A0/en unknown
- 2017-09-26 PH PH12017501767A patent/PH12017501767A1/en unknown
- 2017-10-31 US US15/798,647 patent/US10369142B2/en active Active
-
2019
- 2019-06-27 US US16/454,353 patent/US10946009B2/en active Active
-
2020
- 2020-02-04 JP JP2020016858A patent/JP2020073583A/ja not_active Withdrawn
- 2020-03-17 CY CY20201100246T patent/CY1122828T1/el unknown
-
2021
- 2021-02-08 US US17/248,787 patent/US11452723B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008280351A5 (https=) | ||
| CA2561109A1 (en) | Gastric retention system | |
| JPS61176521A (ja) | 投与形態物の処理方法 | |
| FI3562486T3 (fi) | Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa | |
| ES2977953T3 (es) | Comprimido | |
| JP2010510260A5 (https=) | ||
| JP2018514523A5 (https=) | ||
| BR112016001822B1 (pt) | Comprimido farmacêutico compreendendo ácido acetilsalicílico e clopidogrel e seu processo de fabricação | |
| JP2014503523A5 (https=) | ||
| JP2016515523A5 (https=) | ||
| RU2013141534A (ru) | Составы l-ментола, состоящие из множества частиц, и связанные с ними способы | |
| CN108367078A (zh) | 医药微丸的干粉包衣组合物 | |
| JP2010540547A5 (https=) | ||
| JP2019509345A5 (https=) | ||
| CZ2015272A3 (cs) | Polymerní film s obsahem fotosensitizérů a jeho použití | |
| WO2016142708A3 (en) | Pharmaceutical composition | |
| Osei-Yeboah et al. | A top coating strategy with highly bonding polymers to enable direct tableting of multiple unit pellet system (MUPS) | |
| WO2012053785A3 (ko) | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 | |
| JP2015508411A5 (https=) | ||
| JP2018513138A5 (https=) | ||
| Muschert et al. | Improved long term stability of aqueous ethylcellulose film coatings: importance of the type of drug and starter core | |
| WO2017103945A1 (en) | Pharmaceutical compositions | |
| JP5973170B2 (ja) | 固体分子分散物 | |
| WO2016091805A3 (de) | Naloxon-monopräparat und mehrschichttablette | |
| JP2016033133A5 (https=) |